ÂÜÀòÂÒÂ×

Hendrik Van der Walt is a seasoned executive with extensive experience in the animal health sector, currently serving as the General Manager for Australia and New Zealand at Elanco since July 2008. Key responsibilities include overseeing the separation from Eli Lilly, integrating the Bayer Animal Health acquisition, and driving strategic growth initiatives. Previous roles at Elanco include Chief Operating Officer, where collaboration with the CEO and CFO focused on corporate strategy and margin improvement, and Executive Director of Global Pricing and Margin Improvement, where strategic pricing initiatives were developed. Hendrik's background also includes leadership positions in sales and marketing across various regions, with an emphasis on operational excellence and customer relationships. Educational credentials include a BSc in Agriculture from the University of Pretoria, a Certificate in Financial Management from Cornell University, and a Certificate in Business Analytics from Harvard Business School.